AI
Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
CAPS Medical Completes $3.5 Million Series A Round for Selective Cancer Treatment Technology
07/29/20, 12:05 PM
Location
netanya
Money raised
$3 million
Round Type
series a
CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma device for cancer treatment, today announced the completion of a $3.5 million Series A financing round. The round will enable CAPS Medical to perform its first clinical trial and assist the company in further developing its portfolio for treatments of solid tumors. The company, founded in 2018 by MEDX Xelerator, an Israeli Innovation Authority incubator, expects that the results of these studies will contribute to achieving regulatory clearance in the U.S. market
Company Info
Company
Caps Medical
Location
netanya, center district, israel
Additional Info
Founded in 2018, CAPS Medical has created a highly selective Non-Thermal Atmospheric Plasma cancer treatment device, able to treat a wide range of solid tumors without impacting surrounding tissue. CAPS Medical addresses the $100 billion oncology market.
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.